Fingolimod
In Stock•Starting at $8 for 1 mg•Purity ≥ 98%
| CAS No. | 162359-55-9 |
|---|---|
| MDL No. | MFCD14705150 |
| MF | C19H33NO2 |
| MW | 307.50 |
| InChI Key | KKGQTZUTZRNORY-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $8 | In Stock | |
| 5 mg | 98% | $9 | In Stock | |
| 10 mg | 98% | $11 | In Stock | |
| 100 mg | 98% | $34 | In Stock | |
| 250 mg | 98% | $40 | In Stock |
Product Information
Fingolimod is an aminodiol consisting of propane-1,3-diol with amino and 2-(4-octylphenyl)ethyl substituents at the 2-position. It is a sphingosine 1-phosphate receptor modulator used to treat relapsing-remitting multiple sclerosis. As a prodrug, it is phosphorylated by sphingosine kinase to form the active metabolite fingolimod-phosphate, a structural analog of sphingosine 1-phosphate. It functions as an immunosuppressive agent, prodrug, antineoplastic agent, sphingosine-1-phosphate receptor agonist, and CB1 receptor antagonist. It is also an aminodiol and a primary amino compound, acting as the conjugate base of fingolimod(1+).
| CAS No. | 162359-55-9 |
|---|---|
| Product Name | Fingolimod |
Biological Targets
S1PR5·S1PR2·S1PR4·S1PR3·S1PR1
Associated Conditions
anaplastic astrocytoma·Rett syndrome·primary progressive multiple sclerosis·chronic inflammatory demyelinating polyradiculoneuropathy·Renal insufficiency·
* The information provided here is compiled from public sources and is for reference only.
